Form I17 Monitoring CRE/CRPA in Companion Animals to/from Humans

Form Approved

OMB Control No.: 0920-1310

Expiration date: XX/XX/XXXX

Annual Evaluation and Performance Measurement Report (I.17- MONITORIING CRE/CRPA IN COMPANION ANIMALS TO/FROM HUMANS)

Annually, each funded laboratory is required to report to CDC evaluation and performance measures. Data are used to indicate progress made toward program outcomes. These summary reports have to be uploaded to the ELC CAMP at the end of each funding year. Required performance measures are listed below.

1. Proportion of companion animal isolates determined to be CP-CRE or CP-CRPA (report CRE and CRPA separately)

a. Numerator: Number of CP-CRE or CP-CRPA companion animal isolates confirmed.

b. Denominator: Number of companion animal Enterobacterales or P. aeruginosa isolates tested for carbapenemase production/carbapenemase genes

c. Calculated: Percentage of CP-CRE or CP-CRPA among all companion animal isolates tested.

2. Number of companion animal CP-CRE and CP-CRPA isolates undergoing WGS and number of sequences uploaded to NCBI:

Public reporting burden of this collection of information is estimated to average 20 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information.  An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB Control Number.  Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer, 1600 Clifton Road NE, MS H21-8, Atlanta, Georgia 30333; ATTN: PRA 0920-1310